Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorViome
About this trial
30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.
Eligibility criteria
Qualifiers
Adult females > 18 years old
Advanced or recurrent gynecological cancer patients from AHMG Advent Health Orlando Gynecologic Oncology Group
Patients for whom an immunotherapy regimen has been ordered
Disqualifiers
Patients unable to provide fecal specimens at three time points
Patients unable to read or understand informed consent
Proton pump inhibitors (PPIs)
Metformin
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Viome
Lead sponsor
AdventHealth
Collaborator
Source ClinicalTrials.gov